Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime. BV is characterized by unpleasant odors, ...
MeMed, a leader in host-response technology, today announced that Health Canada has granted Medical Device License (MDL) for ...
MeMed BV test MeMed BV runs on the MeMed Key platform and provides results within 15 minutes. The Food and Drug Administration has cleared the MeMed BV ® test for distinguishing between bacterial and ...
Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime. BV is characterized by unpleasant odors, ...
Opens up testing to decentralized settings including urgent care centers which see 100 million patient visits for potential infections in the US annually Significant milestone towards making bacterial ...
Vaginal infections remain one of the most common yet frequently misdiagnosed reasons for gynecological consultations worldwide. Technology Networks spoke with Dr. Nico Michel, a lifecycle leader at ...
One in three women are affected by bacterial vaginosis (BV), a common but poorly understood condition caused by an imbalance of vaginal bacteria that can cause discomfort and pain. BV is treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results